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Abstract 
Background: Psychostimulant drug use is commonly associated with drug‑related infection, including the human 
immunodeficiency virus (HIV). Both psychostimulant use and HIV infection are known to damage brain white matter 
and impair cognition. To date, no study has examined white matter integrity using magnetic resonance imaging (MRI) 
diffusion tensor imaging (DTI) in chronic psychostimulant users with comorbid HIV infection, and determined the 
relationship of white matter integrity to cognitive function.
Methods: Twenty‑one subjects (mean age 37.5 ± 9.0 years) with a history of heavy psychostimulant use and HIV 
infection (8.7 ± 4.3 years) and 22 matched controls were scanned on a 3T MRI. Fractional anisotropy (FA) values were 
calculated with DTI software. Four regions of interest were manually segmented, including the genu of the corpus 
callosum, left and right anterior limbs of the internal capsule, and the anterior commissure. Subjects also completed a 
neurocognitive battery and questionnaires about physical and mental health.
Results: The psychostimulant using, HIV positive group displayed decreased white matter integrity, with significantly 
lower FA values for all white matter tracts (p < 0.05). This group also exhibited decreased cognitive performance on 
tasks that assessed cognitive set‑shifting, fine motor speed and verbal memory. FA values for the white matter tracts 
correlated with cognitive performance on many of the neurocognitive tests.
Conclusions: White matter integrity was thus impaired in subjects with psychostimulant use and comorbid HIV 
infection, which predicted worsened cognitive performance on a range of tests. Further study on this medical comor‑
bidity is required.
Keywords: Comorbidity, Diffusion tensor imaging, Human immunodeficiency virus, Magnetic resonance imaging, 
Neurocognitive, Psychostimulant
© 2015 Tang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
*Correspondence:  al.barr@ubc.ca 
†Victor M. Tang and Donna J. Lang contributed equally to this work
6 Department of Pharmacology, University of British Columbia, 2176 
Health Sciences Mall, Vancouver, BC V6T1Z3, Canada
Full list of author information is available at the end of the article
Page 2 of 15Tang et al. BMC Res Notes  (2015) 8:515 
Background
Illicit drug use represents a pervasive public health con-
cern, creating substantial cost and burden for individuals 
and society. Psychostimulant drugs, including cocaine, 
amphetamines and methamphetamine are among the 
most commonly used substances worldwide [1]. Concern 
about the widespread use of psychostimulants includes the 
health risks associated with chronic substance use [2, 3].
Research with magnetic resonance imaging (MRI) has 
helped to elucidate the deleterious effects of psycho-
stimulant use on brain structure, with consistent abnor-
malities being found within fronto-striatal systems [4]. 
Diffusion tensor imaging (DTI) has been used to examine 
the effects of psychostimulant use on the white matter 
tracts of the brain. DTI measures the directional coher-
ence of the diffusion of water in tissue. A reduction in 
anisotropy indicates reduced organization or integrity of 
white matter, usually as a result of axonal compromise, or 
increased membrane permeability (e.g. demyelination) 
[5]. The most common method for quantifying anisot-
ropy is through fractional anisotropy (FA). Researchers 
have reported decreased FA in frontal white matter 
in methamphetamine users [6, 7] and in frontal white 
matter and the corpus callosum of cocaine users [8, 9] 
(Table 1). Decreases have also been found in major white 
matter tracts connecting the right and left hemispheres, 
with decreased FA in the genu of the corpus callosum 
associated with methamphetamine use [10, 11] and 
cocaine use [9, 12].
When studying the effects of drug use on the brain, 
it is also important to consider the clinically complex 
issue of comorbidity that is common in many psycho-
stimulant users. The incidence of infectious disease in 
psychostimulant users is high, including the human 
immunodeficiency virus (HIV) [13] that may be acquired 
by intravenous drug use and unsafe sexual practices [14]. 
In HIV/AIDS affected individuals who are not psycho-
stimulant abusers, several brain regions have been shown 
to exhibit decreased FA values [15–18] (Table 2). White 
matter changes are related to duration of infection, and 
are more affected in those with cognitive deficits [19]. 
Cognitive impairment is seen in as much as 63 % of this 
population [20] and such deficits correlate with FA value 
decreases [21–23].
In the present study, our goal was to examine the neu-
roanatomical and cognitive changes in psychostimulant 
users with comorbid HIV infection, using DTI. To our 
knowledge, there has not been a study of FA values in this 
comorbid population, even though there known effects of 
psychostimulant use and HIV on white matter integrity. 
We have recently reported that comorbid addiction and 
infectious disease can significantly impact factors such 
as everyday functioning [24, 25]. In the present study, 
we have focused specifically on the key frontotemporal 
white matter pathways of the genu of the corpus callo-
sum, the right and left anterior limbs of the internal cap-
sule, and the anterior commissure. It has been proposed 
that forebrain regions that are connected by these tracts 
are most affected by psychostimulant use, as they receive 
dopamine projections from the midbrain, which are a key 
substrate of the toxic effects of psychostimulant expo-
sure [2], and are important for neurocognitive function. 
Participants were also subject to a comprehensive neu-
ropsychological test battery in order to assess function in 
multiple cognitive domains.
Methods
Participants
Twenty-one HIV-positive subjects seeking care for psy-
chostimulant use (the “patient” group) were recruited 
from St. Paul’s and Vancouver General Hospital in Van-
couver, Canada. Referrals were through staff clinicians in 
the emergency department. Patients were ≥19 years old, 
had a history of psychostimulant exposure, HIV-posi-
tive and could provide informed consent. Twenty-two 
age, gender and premorbid IQ matched controls were 
recruited from the same geographical community. All 
subjects in the study provided written consent. The study 
was approved by the UBC Clinical Research Ethics Board 
(CREB), in accordance with Canadian tri-council guide-
lines and the Declaration of Helsinki. Exclusion criteria 
included: surgery in previous 6 months, pregnancy, metal 
implants, claustrophobia, uncorrectable visual impair-
ment and IQ <70.
MRI acquisition
A 3Tesla MRI (Philips System) with an eight chan-
nel head coil was used. A T1-weighted 3D fast spoiled 
gradient echo (SPGR) inversion recovery prepped 
series for volumetric assessment was performed for 
region of interest (ROI) seeding in structural space in 
the transverse plane with: TR  =  7.7  ms, TE  =  3.6  ms, 
flip angle =  8°, FOV =  256 ×  170 ×  200  mm, acquisi-
tion and reconstruction matrices  =  256  ×  256, 170 
slices, slice thickness  =  1  mm, gap  =  0, 1  mm iso-
tropic voxel, SENSE  =  0. DTI images were acquired in 
the transverse plane with TR =  7500  ms, TE =  54  ms, 
b-value = 800, 16 directions, flip angle = 90°, acquisition 
matrix = 112 × 112, reconstruction matrix = 110 × 110, 
voxel dimensions  =  0.875  mm  ×  0.875  mm  ×  2, 
FOV  =  224  ×  144  ×  224  mm, 72 slices, slice thick-
ness = 2 mm, gap = 0, SENSE = 1.
ROI manual segmentation
The rostrum and genu of the corpus callosum, the right 
and left anterior limb of the internal capsule, and the 
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anterior commissure were manually segmented on the 
T1-SPGR structural scans using the interactive mask-
ing tool from FMRIB Software Library 4.1. The anterior 
limb of the internal capsule was well visualized as a vis-
ible white matter tract bounded medially by the caudate 
and laterally by the putamen on the axial plane, seven 
slices superior to the first visualization of the anterior 
commissure.
The anterior commissure was manually segmented 
axially. The analysis of this ROI was restricted to fibers 
that crossed two geometrically placed ROIs 4 mm lateral 
on each side of a mid-sagittal line drawn in the coronal 
plane. Borders of the corpus callosum genu were traced 
on the mid-sagittal slice in the sagittal plane. The poste-
rior border was defined with a vertical line marked by the 
anterior-most point of the inner convexity of the ante-
rior callosum. To remove extraneous fibers and restrict 
analysis to fronto-temporal connections, additional ROIs 
from automatically segmented masks were applied to 
restrict fiber analysis to target tracts. For the genu, all 
other regions of the corpus callosum were excluded, as 
well as the fornix. An occipital lobe mask excluded fibers 
to the corpus callosum genu, anterior limb of the inter-
nal capsule, and anterior commissure. Intra-rater reli-
abilities for FA values for all ROIs. Manual ROI selection 
was repeated on a random set of five controls and five 
patients for each tract. Intra-class correlation coefficients 
were 0.83–0.96 for all tracts.
Image processing
Image processing was performed on an AppleMacPro 
Tower Quad Core Intel computer, OS X version 10.5.8. 
Raw images were converted to NIFTI format with 
MICRON dcm2nii shareware. Processing of diffusion 
weighted data for VBM-style analysis, specifically motion 
and standard eddy current distortion correction as rec-
ommended by FSL (see FRMRIB-FDT v2.0 pipeline), 
local modeling of diffusion parameters, spatial registra-
tion, tractography and local fitting of diffusion tensors 
was performed with FMRIB Diffusion Toolbox as part 
of the FMRIB Software Library (FSL v4.1.4 http://www.
fmrib.ox.ax.uk/fsl). DTI data were registered from diffu-
sion space to structural space and from structural space 
to standard (MN152) space. Prior to analysis, all dif-
fusion scans were reconstructed to a voxel dimension 
of 0.88 ×  0.88 ×  2.0 to mitigate partial volume effects. 
Tracts were generated from the manual ROI seeds. All 
tracts were subsequently normalized by seed size. The 
minimum probability threshold for normalized tracts 
was set to 0.2 to avoid over-inclusion of non-tract vox-
els. Volume extraction of frontal pathways from FSL 
was based on standardized automated reconstruction 
from the Bayesian framework, in which probabilistic 
estimation from the diffusion images is calculated based 
on multiple compartments of anisotropic diffusion and 
a single compartment of isotropic diffusion per voxel. 
This is expressed as the diffusion data at any given indi-
vidual voxel as a function of volume and orientation of 
any given compartment. FSL applies automated summa-
tion of the voxel volumes associated with the manually 
placed tractography seed at the recommended threshold 
to calculate the final tract volume. One scan had to be 
excluded due to motion artifact. All scans were reviewed 
by a neuroradiologist for evidence of brain injury which 
could have affected DTI indices; no scans were required 
to be excluded from the analysis.
Volumetric segmentation was performed with Free-
surfer. Processing included motion correction, removal 
of non-brain tissue, automated Talairach transformation, 
segmentation of the subcortical white matter and deep 
gray matter volumetric structures, intensity normali-
zation, tessellation of the gray/white matter boundary, 
automated topology correction, and surface deformation 
via intensity gradients [26]. Maps were created using spa-
tial intensity gradients across tissue classes and are there-
fore not simply reliant on absolute signal intensity.
Cognition
Before testing, subjects were asked if they were cur-
rently experiencing the effects of a drug. If they answered 
affirmatively, or the research assistant suspected them 
of having just used a drug, they were excluded from the 
study. Premorbid intellectual functioning was estimated 
from the Full Scale IQ score on the North American 
adult reading test (NAART). All subjects completed a 
comprehensive neuropsychological battery. Multiple cog-
nitive domains were evaluated (neurocognitive tests and 
outcome variables listed in parentheses); including pro-
cessing/visual scanning speed and cognitive set-shifting 
(trail making test; TMT; Trail A and B completion time), 
fine motor speed and dexterity (Grooved Pegboard; 
dominant and non-dominant hand completion time), 
verbal learning and memory (California verbal learn-
ing test-II; CVLT-II; total recall trials 1–5, short delay 
free recall, long delay free recall, and total recognition 
discriminability).
The computerized Cambridge neuropsychological test 
automated battery (CANTAB; [27]) was used to exam-
ine sustained attention (rapid visual information pro-
cessing; RVP; A′ signal detection measure of sensitivity), 
and components of attentional set-shifting (intra/extra 
dimensional shift; IED; concept formation errors and 
concept switching errors). Failure to complete a particu-
lar stage on the IED subtest ended the task. Therefore, 
adjusted error scores for all non-completers were estab-
lished by adding one error to the error total observed in 
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the participant who made the most errors yet completed 
the given stage.
Score distributions were examined for normality 
and outliers. For several variables (e.g., Trails A and B, 
Grooved Pegboard, and RVP A′) outliers were identified, 
and adjustments to these scores were made according 
to [28]. To control for the effects of years of education, 
which differed significantly between groups, unstandard-
ized residuals were calculated by regressing raw cognitive 
scores for the entire sample on education. For consist-
ency, the signs of unstandardized residuals for certain 
variables (e.g., errors or speed) were reversed (i.e., mul-
tiplied by −1) so that lower values represented worse 
performance.
Demographics
Subjects provided demographic information. Drug use 
over the previous 30  days was collected through the 
Maudsley Addiction Profile [29] for both the patient 
group and the control group. A cumulative total of days 
in the month spent using psychostimulant drugs was 
also determined, whereby each day spent using a specific 
psychostimulant drug was added together. A urine drug 
screen also was obtained for both groups which detected 
recent use of amphetamines, barbiturates, benzodiaz-
epines, cocaine (including crack), marijuana, methadone, 
3,4-methylenedioxymethamphetamine, opiates and tri-
cyclic antidepressants. Confirmation of HIV status was 
obtained from patient medical charts. For subjects with 
HIV, an additional questionnaire was administered to 
gather information about their illness. This is a 21 item 
questionnaire that includes information about time of 
infection, past and current treatment, related medical 
conditions and hospitalization. Psychiatric health was 
assessed with the Mini International Neuropsychiatric 
Interview (MINI), which is a well validated structured 
clinical interview that assesses lifetime mental health and 
substance use disorders based on Diagnostic and Sta-
tistical Manual, 4th ed. (DSM-IV) and the International 
Classification of Diseases (ICD)-10 criteria [30]. All sub-
jects were offered the opportunity to complete a com-
plete blood count (CBC) with differential. CD4 and CD8 
counts were also measured while HIV positive status was 
confirmed.
Statistical analysis
A Pearson Chi square (χ2) analysis was performed to 
compare the groups on categorical demographic vari-
ables. Independent t-tests compared mean group FA 
values and cognitive outcome variables for normally dis-
tributed variables. For non-normal cognitive data (TMT 
B and the IED subtests), the non-parametric Mann–
Whitney U test was employed. T-tests were two tailed 
with statistical significance defined as p  <  0.05. Effect 
sizes (ES) for group comparisons were also computed 
using Cohen’s d (corresponding to ES of small  =  0.2, 
medium  =  0.5, large  =  0.8). Pearson correlations (r) 
assessed associations between FA values and cognitive 
outcome variables. Analyses were performed using SPSS 
16 software (SPSS Inc., USA).
Results
Demographic variables
The mean age of the patient group was 37.45 (±9.0) 
years, range 22–58 years. The mean age of controls was 
39.55 (±9.0) years, range 20–57 years. The control group 
included 13 males and 9 females. The patient group 
included 14 males and 7 females. Gender distribution 
did not differ between groups (p > 0.46). Subjects did not 
differ in age (p > 0.22) and estimated premorbid intellec-
tual functioning on the NAART test (p > 0.16) [99.7 ± 8.8 
(patients) vs 103.0 ± 6.8 (controls)]. There was a signifi-
cant group difference in mean years of completed educa-
tion (t(41) = 2.79 p < 0.01) [10.29 ± 2.63 years (patients) 
vs 12.05 ± 1.33 years (controls)]. Details on HIV status in 
the patient group are listed in Table 3.
Results of the MINI indicated that 10 subjects in the 
patient group had a lifetime diagnosis of substance-
induced psychosis (versus no controls), 9 a history of 
depression (versus 5 controls), 2 a history of mania 
(versus no controls) and 2 a history of PTSD (versus 2 
controls). All subjects in the patient group met lifetime 
criteria for non-alcoholic psychoactive substance use 
disorder, versus no controls. For bloodwork, 16 of the 
patient group and 17 of the controls completed the blood 
work. Subjects in the patient group exhibited signifi-
cantly lower total white blood cell counts, as well as lower 
CD4 cell counts, higher CD8 cell counts, and a lower 
CD4:CD8 ratio (Table 4).
Drug use
Drug use over the previous 30  days is listed in Table  5 
(only substances where more than one subject used the 
drug are included). The groups differed significantly in 
alcohol, heroin, cocaine powder, crack cocaine, ampheta-
mines and cannabis use, with alcohol use higher in the 
Table 3 HIV status
Patients (n = 21)
Average duration of HIV infection 8.7 ± 4.3 years
Current status HIV or AIDS HIV 18 (86 %), AIDS 3 (14 %)
Previous HIV‑related hospitalizations (Y/N) 11Y (53 %), 10N (47 %)
Currently treated for HIV(Y/N) 15Y (71 %), 6N (29 %)
If not currently treated, were previously 4Y (66 %), 2N (33 %)
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controls and every other drug higher in the patient group. 
The most commonly used drug in the patient group was 
crack cocaine, followed by cocaine powder and canna-
bis. While only six subjects in the patient group reported 
using amphetamines in the previous month, all subjects 
in this group had used some form of psychostimulant 
drug (amphetamines, cocaine powder or crack cocaine) 
in the previous 30  days, with psychostimulants being 
used an average of 32 cumulative “days” per person 
during this period. The results of the urine drug screen 
correlated well with self-reported drug use, with 18 of 
the 21 subjects in the patient group testing positive for 
recent cocaine or amphetamine use (previous 48 h), and 
only one subject in the control group testing positive for 
cocaine.
Fractional anisotropy
Summary FA values are shown in Table  6. Significant 
between-group differences in FA values were seen in 
the corpus callosum genu (t(40)  =  3.84 p  <  0.001), left 
(t(40) =  3.23 p  <  0.005) and right (t(40) =  2.30 p  <  0.05) 
anterior limbs of the internal capsule, and in the ante-
rior commissure (t(40) = 2.10 p < 0.05), as FA values were 
lower for the patient group in all of these white matter 
pathways (Fig.  1). Correlational analyses did not reveal 
relationships between FA and age in either group for any 
ROI. There were also significant group differences for 
medial diffusivity (MD) and radial diffusivity (RD) values 
for all pathways other than the anterior commissure, and 
differences in axial diffusivity (AD) values for both the 
left and right anterior limb of the internal capsule path-
ways. Total white matter volume in the patient group was 
smaller than the control group, but this narrowly failed to 
obtain significance when co-varied for total brain volume 
(p = 0.052).
Neurocognitive performance
The patient group performed worse than controls on 
all cognitive variables (Table  7). Group differences 
were seen in cognitive set-shifting (TMT B; U =  147.0, 
z = −2.04, p < 0.05), fine motor speed and dexterity bilat-
erally (Grooved Pegboard; dominant hand: t(41) = −3.96, 
p = 0.001; non–dominant hand: t(41) = −3.80, p = 0.001), 
word list acquisition (CVLT-II total recall: t(41) = −2.37, 
p < 0.05) and immediate recall (CVLT-II short delay free 
recall: t(41) = −2.13, p < 0.05).
Relationship between DTI FA values and cognition
Exploratory analyses between FA values and cognitive 
measures for the group as a whole revealed a number of 
significant associations (Table  8). For the anterior com-
missure, lower FA values were significantly correlated 
with slower fine motor speed and dexterity with the dom-
inant hand (Grooved pegboard; r  =  −0.338; p  <  0.05). 
Lower FA values in this pathway were also associated 
with poorer sustained attention (RVP A′; r  =  0.364; 
p < 0.005).
For the left anterior limb of the internal capsule, lower 
FA values were significantly correlated with slower fine 
motor speed and dexterity bilaterally (Grooved Pegboard 
dominant hand: r  =  −0.468, p  <  0.005; non-dominant 
hand: TMT Trail B; r = −0.409, p < 0.01). Higher FA val-
ues were associated better sustained attention (RVP A′; 
r = 0.403, p < 0.05). Further, higher FA values predicted 
better verbal learning (CVLT total recall; r  =  0.419, 
p < 0.01) and memory, including after both short (CVLT 
Short Delay; r = 0.376, p = 0.017) and long delays (CVLT 
Long Delay; r = 0.416, p = 0.008).
Table 4 Results of complete blood count and differential
Numbers indicate mean score (±SEM) for either the patient or control group. 
Significant difference between groups * p < 0.05, ** p < 0.01
Controls (n = 17) Patients (n = 16)
White blood cell count (giga/L) 6.76 ± 1.81 4.93 ± 1.61**
Helper CD4 (%) 45.35 ± 5.32 28.00 ± 16.04**
Helper CD4 Absolute number 
(per µL)
874.11 ± 192.32 435.00 ± 310.07**
Suppressor CD8 (5) 24.53 ± 7.53 45.94 ± 19.94**
Suppressor CD8 Absolute  
number (per µL)
480.59 ± 198.82 836.88 ± 735.46
CD4:CD8 ratio 2.04 ± 0.71 0.96 ± 1.09**
Table 5 Substance use over prior 30 days
Numbers indicate either number of subjects per group using the drug (# using) 
or mean number of days per 30 days spent using the drug (# days) ± SEM. 
Significant difference between groups * p < 0.05, ** p < 0.01. For number of days 
using each drug, mean daily intake (± SEM) for both groups for cases who used 
the drug is included in square parentheses
Controls (n = 22) Patients (n = 21)
Alcohol (# using) 16 7**
Alcohol (# days) [4.2 ± 3.7 units] 4.6 ± 5.7 2.4 ± 6.5
Heroin (# using) 0 7**
Heroin (# days) [0.2 ± 0.15 g] 0 3.4 ± 7.9*
Cocaine powder (# using) 2 13**
Cocaine powder (# days) 
[0.52 ± 0.76 g]
1 9.4 ± 12.1**
Crack cocaine (# using) 0 19**
Crack cocaine (# days) 
[0.92 ± 1.65 g]
0 18.3 ± 12.3**
Amphetamines (# using) 0 6**
Amphetamines (# days) 
[0.38 ± 0.40 g]
0 4.0 ± 8.6*
Cannabis (# using) 4 13**
Cannabis (# days) [0.95 ± 0.68 g] 1.6 ± 5.6 14.3 ± 13.9**
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Table 6 DTI measures of white matter tracts in HIV positive patients with history of psychostimulant use
Numbers indicate mean score (±SEM) for fractional anisotropy (FA), medial diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD) values for either the patient 
or control group; units for MD, AD and RD are (mm2/s × 10−3). Tracts include the genu of the corpus callosum (CC), left and right anterior limb of the internal capsule 
(ALIC) and the anterior commissure (AC). Values represent group mean ± SD
* Significant difference between groups p < 0.05
Controls (n = 22) Patients (n = 20) Effect size (d)  
and p value
Genu of CC
 FA 0.3838 ± 0.0254 0.3517 ± 0.0289 1.184; 0.0001*
 MD 0.910 ± 0.054 0.951 ± 0.039 −0.864; 0.008*
 AD 1.283 ± 0.071 1.301 ± 0.047 −0.296; 0.324
 RD 0.723 ± 0.052 0.775 ± 0.046 −1.056; 0.002*
Right ALIC
 FA 0.3555 ± 0.0229 0.3391 ± 0.0233 0.710; 0.027*
 MD 0.907 ± 0.064 0.953 ± 0.060 −0.740; 0.022*
 AD 1.245 ± 0.071 1.288 ± 0.061 −0.647; 0.044*
 RD 0.737 ± 0.064 0.785 ± 0.063 −0.756; 0.020*
Left ALIC
 FA 0.3798 ± 0.0307 0.3539 ± 0.0190 1.002; 0.002*
 MD 0.857 ± 0.055 0.914 ± 0.042 −1.157; 0.001*
 AD 1.208 ± 0.061 1.254 ± 0.049 −0.827; 0.011*
 RD 0.681 ± 0.058 0.745 ± 0.042 −1.254; 0.0001*
AC
 FA 0.3782 ± 0.0499 0.3509 ± 0.0332 0.638; 0.042*
 MD 1.107 ± 0.189 1.142 ± 0.200 −0.180; 0.558
 AD 1.539 ± 0.187 1.555 ± 0.239 −0.075; 0.773
 RD 0.937 ± 0.184 0.893 ± 0.191 0.235; 0.455
Fig. 1 Regions of interest include white matter pathways in the forebrain that are important in neurocognitive function and known to be damaged 
by HIV infection or psychostimulant use. Pathways include the a anterior commissure (sagittal view), b left (blue) and right (red) anterior limbs of the 
internal capsule (axial view) and c corpus callosum genu (axial view)
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For the right anterior limb of the internal capsule, FA 
values correlated negatively with both the dominant 
(r = −0.384, p = 0.014) and non-dominant (r = −0.318, 
p =  0.046) hand on the grooved pegboard task, reflect-
ing slower fine motor speed and dexterity. Also, as FA 
scores increased, verbal learning performance was higher 
(CVLT total recall; r = 0.343, p = 0.03).
For the corpus callosum genu, FA values corre-
lated negatively with both the dominant (r  =  −0.475, 
p =  0.002) and non-dominant (r = −0.410, p =  0.009) 
hand on the grooved pegboard task. Higher FA values 
predicted better sustained attention (RVP A′; r = 0.335, 
p  =  0.037). Finally, there was a negative correlation 
between FA values and the IED pre-EDS errors score 
(r  =  −0.317, p  =  0.046), reflecting poorer concept 
formation.
Discussion
To our knowledge, this is the first study to examine cog-
nitive function and white matter integrity in subjects 
with a history of heavy psychostimulant use and comor-
bid HIV infection, compared to healthy, matched control 
Table 7 Comparison of neurocognitive data between groups
Numbers indicate raw scores of group mean ± SEM with no mathematical transformations (lower scores represent better performance on variables measured in 
seconds or errors)
Significant difference between groups * p < 0.05, ** p < 0.01
TMT trail making test, RVP rapid visual information processing, CVLT California verbal learning test, IED intra/extra dimensional shift
a n = 20; test statistic = t value from independent t-tests or b Mann–Whitney U (z) value from the non-parametric Mann–Whitney U test for non-normal data
Test-variable Controls (n = 22) Patients (n = 21) Test statistic Effect size (d)
TMT trail A (s) 31.05 ± 1.22 33.81 ± 2.46 −0.74 −0.23
TMT trail B (s)b 66.77 ± 4.70 101.29 ± 10.30 147.0 (−2.04)* −0.65
Grooved pegboard dominant hand (s) 65.86 ± 1.95 95.05 ± 5.49 −3.96** −1.23
Grooved pegboard non‑dominant hand (s) 71.05 ± 2.03 90.35a ± 4.05 −3.80** −1.21
RVP A′ 0.89 ± 0.01 0.86a ± 0.01 −1.84 −0.56
CVLT‑II total recall 45.86 ± 1.98 34.33 ± 2.47 −2.37* −0.72
CVLT‑II short delay free recall 10.23 ± 0.74 7.00 ± 0.67 −2.13* −0.65
CVLT‑II long delay free recall 10.45 ± 0.61 7.48 ± 0.79 −1.67 −0.51
CVLT‑II recognition discriminability 3.04 ± 0.19 2.47 ± 0.17 −1.30 −0.40
IED EDS errorsb 9.55 ± 2.16 17.10 ± 2.40 168.0 (−1.53) −0.61
IED Pre‑EDS errorsb 21.41 ± 4.34 43.86 ± 7.43 191.0 (−0.972) −0.68
Table 8 Associations between FA values and cognitive measures
Numbers represent Pearson correlations between cognitive scores and FA values
Significant correlation * p < 0.05, ** p < 0.01
AC anterior commissure, LALIC left anterior limb of the internal capsule, CC corpus callosum, RALIC right anterior limb of the internal capsule, TMT trail making test, 
GP grooved pegboard, DH dominant hand, NDH non-dominant hand, RVP rapid visual information processing, CVLT-II California verbal learning test-II, SDFR short-
delay free recall, LDFR long-delay free recall, IED intra-extra dimensional shift, EDS extradimensional
Cognitive domain Measure AC LALIC CC genu RALIC
Visual scanning speed TMT trails A −0.051 −0.288 −0.157 −0.114
Cognitive set‑shifting TMT trails B −0.274 −0.409** −0.289 −0.182
Fine motor speed GP–DH −0.338* −0.468** −0.475** −0.384*
Fine motor speed GP–NDH −0.145 −0.465** −0.410** −0.318*
Sustained attention RVP A′ 0.364* 0.403* 0.335* 0.094
Verbal learning CVLT‑II total recall 0.235 0.419** 0.206 0.343*
Immediate recall CVLT‑II SDFR 0.234 0.376* 0.065 0.242
Delayed recall CVLT‑II LDFR 0.222 0.416** 0.098 0.184
Verbal recognition CVLT‑II recognition 0.055 0.247 0.086 0.229
Concept shifting IED EDS errors −0.122 −0.053 −0.280 0.052
Concept formation IED Pre‑EDS errors −0.080 −0.089 −0.317* −0.003
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subjects. The main findings of the present study are that 
the patient group exhibited significantly lower white mat-
ter integrity, indicated by decreased FA values, in the four 
important white matter tracts of the anterior commis-
sure, left and right anterior limb of the internal capsule, 
and the genu of the corpus callosum. With the excep-
tion of the anterior commissure, all tracts also showed 
a significant increase in MD and RD, suggesting that 
increases in axonal membrane permeability, for exam-
ple by processes such as demyelination, may underlie the 
observed decrease in FA values. The patient group also 
displayed widespread neurocognitive impairment, which 
was significant in tasks that assess cognitive set-shifting, 
fine motor speed and verbal memory.
All subjects were recruited from the urban setting of 
the Downtown Eastside of Vancouver, which represents 
one of the poorest neighborhoods in Canada, with high 
rates of drug use, poverty, infectious disease and crime 
[31]. The mean age of the patient group was 37.5  years 
and length of HIV infection was 8.7  years. A majority 
of the patient group completed blood work and exhib-
ited laboratory changes consistent with the literature 
on HIV [32], including decreased total white blood cell 
counts, decreased CD4 cell counts (immunodeficiency), 
increased CD8 cell counts (immunosuppression) and 
a lower CD4:CD8 ratio. While laboratory values in the 
patient group were lower than controls, most absolute 
values were close to accepted norms (http://aids.gov/
index.html), suggesting that most subjects in the patient 
group were responding to treatment for HIV (although 
viral loads were not measured). Drug use was assessed 
over the 30  days prior to the interview. High rates of 
psychostimulant use were evident in all subjects in the 
patient group, which included powder cocaine, crack 
cocaine and amphetamines. Heroin and cannabis use 
were also common, indicating that drug use in this popu-
lation is heterogeneous, and is consistent with simultane-
ous polysubstance use in an urban setting [33, 34]. The 
overall picture of the patient population is therefore that 
of individuals struggling not only with serious drug use 
and HIV infection, but potentially a host of additional 
medical co-morbidities. It is noteworthy that there was 
a significantly greater proportion of the control group 
that consumed alcohol than the patient group. Absolute 
amounts of alcohol consumed over the prior 30 days were 
not excessive in the control group (4.6 ± 5.7 units) so it 
seems unlikely that this could account for group differ-
ences in FA values, but this requires further verification.
The novel observation that subjects in the patient 
group had decreased white matter integrity in the four 
different forebrain pathways adds to our knowledge of the 
deleterious effects of comorbid HIV infection in heavy 
psychostimulant users on white matter in the brain [35]. 
Previous DTI studies in HIV positive subjects reported 
either a decrease in FA values [36] or no difference from 
controls [23, 37] in the genu of the corpus callosum, 
although [38] noted lower FA values only in HIV positive 
subjects with concurrent alcoholism. Other studies have 
reported decreases in FA values for the entire corpus cal-
losum [21, 39], whereas the present study focused on a 
specific sub-region of this tract. Previous studies have not 
observed significant decreases in FA values of the ante-
rior internal capsule in HIV positive subjects compared 
to controls [39–42], although [22] noted decreased FA 
values in the right posterior limb of the internal capsule. 
As such, our study represents the first evidence that the 
bilateral internal capsule pathways are affected in sub-
jects with HIV infection. We are not aware of any studies 
that have measured FA values of the anterior commissure 
in HIV positive subjects.
The effects of psychostimulant drugs on white matter 
integrity have been the focus of several previous studies. 
The FA values in the genu of the corpus callosum were 
either decreased [12, 43] or not different [8, 44] from 
controls in cocaine users, while FA values were globally 
decreased compared to controls in current or former 
methamphetamine users [10, 11, 45]. We are not aware 
of prior reports of psychostimulant use on FA values for 
either the internal capsule or the anterior commissure. In 
this regard, the current observations are consistent with 
previous changes reported for the genu of the corpus cal-
losum, and suggest that additional frontotemporal white 
matter pathways that control neurocognitive processes 
may be affected by comorbid HIV infection in heavy psy-
chostimulant users.
In the present study, the patient group exhibited sub-
stantially lower performance across multiple cognitive 
domains compared to controls, which likely reflects in 
part the effects of HIV infection. While there is substan-
tial variability in neurocognitive impairment in patients 
with HIV, deficits are commonly detected in the areas of 
speed of information processing [46], fine motor speed 
and dexterity [47], aspects of learning and memory (i.e., 
prospective memory, retrieval, etc.) [48] and multiple 
domains of executive functioning (i.e., mental flexibility, 
planning, etc.) [49]. Such deficits may be present even 
when antiviral medication is effective in controlling viral 
load [50]. Psychostimulant drugs, with extended use, can 
also significantly impair cognition [3]. Previous deficits in 
psychostimulant users have been reported with the same 
cognitive tasks that we used, including the Trail Making 
Test [51], grooved pegboard [52], CVLT [53], and CAN-
TAB IED task [54].
Importantly, white matter integrity for the four tracts 
in the present study was significantly correlated with 
cognitive performance, indicating that decreased FA 
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values and consequent loss of white matter integrity in 
the patient group may represent a physiological substrate 
for cognitive impairment in this population. Exploratory 
analyses suggested that all four tracts were each corre-
lated with performance on multiple tasks, and significant 
correlations were consistent with the known neuroanat-
omy of specific tests.
Several previous studies have examined the impact of 
comorbid HIV infection and stimulant use on the brain 
with alternate MRI techniques. HIV positive cocaine 
users displayed impaired brain activation in an fMRI 
study with a delay discounting task [55]. Chang et al. [56] 
noted that the effects of HIV infection and chronic meth-
amphetamine use were additive when they examined 
changes in brain metabolites in frontal white matter with 
MR spectroscopy, indicating that combined psychostim-
ulant drug use and infection caused greater white mat-
ter damage. However, [57] noted that effects of both HIV 
infection and methamphetamine use were not additive in 
altering grey matter regional volumes, and in some basal 
ganglia sub-regions the two factors actually opposed 
each other. These two latter imaging studies suggest that 
white matter in the brain may be particularly vulnerable 
to additive effects of psychostimulant use and HIV infec-
tion. In the present study, the decreases in white matter 
integrity in the patient group included regions (left and 
right anterior limbs of the internal capsule, anterior com-
missure) not previously reported to be affected in HIV 
positive subjects without a confirmed history of psycho-
stimulant abuse.
A potential limitation of this study is the absence of 
control groups that included recent psychostimulant 
users without HIV infection, or HIV positive subjects 
without psychostimulant use. This would have better 
enabled the study to demonstrate unambiguous effects 
of the drugs, or HIV, or an additive effect of both on the 
brain. However, the current patient group represents a 
marginalized population that is commonly encountered 
in urban settings characterized by high rates of pov-
erty and antisocial behaviors such as crime [24, 33], and 
where drug use and HIV infection co-occur with exten-
sive other medical comorbidities to affect brain function 
and structure. Potential comparison groups of HIV posi-
tive subjects without drug use, or psychostimulant users 
without infection (which would reflect different patterns 
of drug use) would likely represent fundamentally differ-
ent populations from our study population, living under 
different and less challenging conditions. Parceling out 
the individual effects of HIV infection or psychostimu-
lant use therefore presents a significant challenge, as it 
would be necessary in this population to control for the 
many other medical and environmental comorbidities 
that may be interacting to affect general physical health 
and the brain [25].
Conclusions
In summary, the present study is the first report of white 
matter integrity, measured by DTI, in psychostimulant 
users with comorbid HIV infection. Four main fronto-
temporal white matter pathways were affected in this 
group, reflected by decreased FA values. Compared to 
controls, psychostimulant users with HIV infection dis-
played broad cognitive impairment, which significantly 
correlated with white matter integrity. Further study is 
required to better understand the influence of additional 
medical comorbidities, resulting largely from drug use, 
on white matter structure and cognition.
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